Novo Nordisk (NVO) has released an update.
Novo Nordisk A/S has announced a share repurchase program, beginning on May 6, 2024, as part of a larger DKK 20 billion buyback plan set to run over 12 months. The company plans to purchase up to DKK 2.2 billion worth of B shares by August 5, 2024, and as of July 12, has already bought back shares worth DKK 9.15 billion at an average price of DKK 877.18 each. Novo Nordisk, a leader in global healthcare, continues to focus on combating serious chronic diseases while expanding access to its treatments worldwide.
For further insights into NVO stock, check out TipRanks’ Stock Analysis page.
